Year
2019
Status
Active
Team
Field
Oncology
Location
Oss (NL)
Fund
BGV III
Genase Therapeutics
Genase Therapeutics is developing a small molecule inhibitor against a metabolic target with therapeutic potential in hematologic malignancies and potentially solid tumors.